ADMA Biologics ADMA Payments to Acquire Property, Plant, and Equipment
Payments to Acquire Property, Plant, and Equipment at other companies
Other financials
Where this comes from
Reported directly by ADMA Biologics in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about ADMA Biologics's payments to acquire property, plant, and equipment.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ADMA Biologics's payments to acquire property, plant, and equipment?
- ADMA Biologics (ADMA) reported payments to acquire property, plant, and equipment of $2.54M in Q1 2026.
- How has ADMA Biologics's payments to acquire property, plant, and equipment changed year-over-year?
- ADMA Biologics's payments to acquire property, plant, and equipment decreased by 45.9% year-over-year, from $4.7M to $2.54M.
- What is the long-term trend for ADMA Biologics's payments to acquire property, plant, and equipment?
- Over 4 years (2021 to 2025), ADMA Biologics's payments to acquire property, plant, and equipment has grown at a 13.7% compound annual growth rate (CAGR), from $13.51M to $22.58M.
- What does payments to acquire property, plant, and equipment mean?
- Measures the cash outflow dedicated to capital expenditures for physical assets necessary to support operations. High levels of investment indicate growth initiatives or maintenance of production capacity, while low levels may suggest capital preservation.